A Case of Type 2 Autoimmune Pancreatitis Suggesting Two Potential Disease Activity Markers.

Kazuki Natsui, Seiichi Yoshikawa, Ayano Kagata, Yusuke Horibata, Hiroyuki Usuda, Manabu Takeuchi, Shuji Terai

Abstract readCase Reports

In one paragraph

Article in Gastro hep advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kazuki NatsuiDepartment of Gastroenterology, Nagaoka Red Cross Hospital, Nagaoka, Niigata, Japan.

Seiichi YoshikawaDepartment of Gastroenterology, Nagaoka Red Cross Hospital, Nagaoka, Niigata, Japan.

Ayano KagataDepartment of Gastroenterology, Nagaoka Red Cross Hospital, Nagaoka, Niigata, Japan.

Yusuke HoribataDivision of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan.

Hiroyuki UsudaDepartment of Pathology, Nagaoka Red Cross Hospital, Nagaoka, Niigata, Japan.

Manabu TakeuchiDepartment of Gastroenterology, Nagaoka Red Cross Hospital, Nagaoka, Niigata, Japan.

Shuji TeraiDivision of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autoimmune pancreatitis (AIP) is divided into 2 main subtypes: type 1 AIP (AIP-1) and type 2 AIP (AIP-2). This report describes a young woman diagnosed with AIP-2 using endoscopic ultrasound-guided tissue acquisition. AIP-2 has been reported less frequently than AIP-1 as serologic abnormalities and other organ involvement except for inflammatory bowel disease are absent. Additional laboratory analyses suggest that serum interleukin-8 and leucine-rich alpha-2 glycoprotein are more efficient disease activity biomarkers than conventional C-reactive proteins. We hope that this case report will contribute to the discovery of diagnostic biomarkers for AIP-2.

Indexed as

AIPGELIL-8LRGType 2 AIP

Identifiers

PMID40487281

DOI10.1016/j.gastha.2025.100635

PMCPMC12138893

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.